30 results
424B3
CHRS
Coherus Biosciences Inc
26 Jul 23
Prospectus supplement
4:59pm
)
Excluded Shares
2.1(b)
FCPA
FDA
3.21(c)
FDA Ethics Policy
3.21(i)
FDCA
3.21(a)
First Merger
Recitals
Form S-4
5.5(a)
Fractional Share Consideration
S-4/A
CHRS
Coherus Biosciences Inc
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
Agent
2.3(a)
Exchange Fund
2.3(b)
Exchange Ratio
8.3(t)
Excluded Shares
2.1(b)
FCPA
FDA
3.21(c)
FDA Ethics Policy
3.21(i)
FDCA
3.21(a)
First Merger
S-4
4l34 admf2v
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
m8wunmvinpipc
16 Jun 23
Business combination disclosure
8:08am
425
89qc47q
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
41n3l28rgd3h7x ks00
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-10.1
inl 6mpgv4
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am